Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

This was the stock's second consecutive day of losses.

Passage Bio reports positive Phase 1/2 trial results for PBFT02 in frontotemporal dementia, with planned protocol amendments for safety optimization.

Data shows excretion of codeine in fingerprint sweat INBS’ System is viable option for non-invasive diagnostic testing NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc.

T is a Novel, Non-Aromatizing Androgen, Offering the Benefits of Testosterone Without Converting to Estradiol Addressing a ...

BOSTON, June 22, 2025--Data from Delve Bio shows the impact of metagenomic sequencing to transform meningitis and encephalitis diagnostics compared to traditional testing.

Intelligent Bio Solutions to present Pharmacokinetic study data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo: New York Tuesday, July 15, 2025, 15: ...

Intelligent Bio Solutions to present pharmacokinetic study data at ADLM 2025 Clinical Lab Expo: New York Saturday, July 12, 2025, 13:00 Hrs [IST] Intelligent Bio Solutions Inc, a ...

The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...

Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...